SCA
ORGO icon

Spearhead Capital Advisors’s Organogenesis Holdings ORGO Stock Holding History

Spearhead Capital Advisors’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-17,500
Closed -$175K – 69
2018
Q2 		$175K Buy
+17,500
New +$175K 0.06% 71

Other funds holding ORGO

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
CFIC
City Financial Investment Company London, United Kingdom $562M AUM 5.93% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Spearhead Capital Advisors's ORGO Position: Q3 2018 in Review

Spearhead Capital Advisors sold out of Organogenesis Holdings (ORGO) in Q3 2018, closing a stake of 17,500 shares — an estimated $175K sold.

Spearhead Capital Advisors first reported a position in ORGO in Q2 2018 and held it in 1 quarter. The position peaked at $175K in Q2 2018. 27 funds tracked by Wall St. Rank hold ORGO as of Q3 2018.

  • Spearhead Capital Advisors reported no remaining Organogenesis Holdings position as of Q3 2018 after selling out during the quarter.
  • Spearhead Capital Advisors sold 17,500 Organogenesis Holdings shares in Q3 2018, an estimated $175K.
  • Spearhead Capital Advisors first reported a position in Organogenesis Holdings in Q2 2018 and held it in 1 quarter.
  • Spearhead Capital Advisors's Organogenesis Holdings position peaked at $175K in Q2 2018.
  • 27 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2018.

Based on Spearhead Capital Advisors's 13F filing for Q3 2018, filed 11 Oct 2018.